|
[1]
|
Borisow, N., Mori, M., Kuwabara, S., Scheel, M. and Paul, F. (2018) Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis. Frontiers in Neurology, 9, Article 888. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Chen, H.X., Zhang, Q., Lian, Z.Y., Liu, J., Shi, Z.Y., Miao, X.H., et al. (2017) Muscle Damage in Patients with Neuromyelitis Optica Spectrum Disorder. Neurology Neuroimmunology & Neuroinflammation, 4, e400. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Baba, T., Nakashima, I., Kanbayashi, T., Konno, M., Takahashi, T., Fujihara, K., et al. (2009) Narcolepsy as an Initial Manifestation of Neuromyelitis Optica with Antiaquaporin-4 Antibody. Journal of Neurology, 256, 287-288. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Uzura, Y., Takeuchi, H., Ashida, S., Fujii, C., Shishido-Hara, Y., Inaba, T., et al. (2022) A Tumefactive Anti-MOG Antibody Associated Disorder Heralding Central Nervous System B-Cell Lymphoma: Case Report on Diagnostic Challenge. Journal of Neuroimmunology, 365, 577823. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Hennes, E.M., Baumann, M., Schanda, K., Anlar, B., Bajer-Kornek, B., Blaschek, A., et al. (2017) Prognostic Relevance of MOG Antibodies in Children with an Acquired Demyelinating Syndrome. Neurology, 89, 900-908. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Juryńczyk, M., Jacob, A., Fujihara, K. and Palace, J. (2018) Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease: Practical Considerations. Practical Neurology, 19, 187-195. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Reindl, M. and Waters, P. (2018) Myelin Oligodendrocyte Glycoprotein Antibodies in Neurological Disease. Nature Reviews Neurology, 15, 89-102. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Avila-Calderón, E.D., Lopez-Merino, A., Sriranganathan, N., Boyle, S.M. and Contreras-Rodríguez, A. (2013) A History of the Development Ofbrucellavaccines. BioMed Research International, 2013, Article ID: 743509. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Yagupsky, P., Morata, P. and Colmenero, J.D. (2019) Laboratory Diagnosis of Human Brucellosis. Clinical Microbiology Reviews, 33, e00073-19. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Akdeniz, H., Irmak, H., Anlar, Ö. and Demiröz, A.P. (1998) Central Nervous System Brucellosis: Presentation, Diagnosis and Treatment. Journal of Infection, 36, 297-301. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Hou, H., Liu, X. and Peng, Q. (2019) The Advances in Brucellosis Vaccines. Vaccine, 37, 3981-3988. [Google Scholar] [CrossRef] [PubMed]
|